IBDEI2VE ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45785,1,4,0)
 ;;=4^Z87.01
 ;;^UTILITY(U,$J,358.3,45785,2)
 ;;=^5063480
 ;;^UTILITY(U,$J,358.3,45786,0)
 ;;=Z92.22^^172^2282^13
 ;;^UTILITY(U,$J,358.3,45786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45786,1,3,0)
 ;;=3^Personal Hx of Monoclonal Drug Therapy
 ;;^UTILITY(U,$J,358.3,45786,1,4,0)
 ;;=4^Z92.22
 ;;^UTILITY(U,$J,358.3,45786,2)
 ;;=^5063631
 ;;^UTILITY(U,$J,358.3,45787,0)
 ;;=Z33.1^^172^2282^16
 ;;^UTILITY(U,$J,358.3,45787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45787,1,3,0)
 ;;=3^Pregnancy,Incidental to
 ;;^UTILITY(U,$J,358.3,45787,1,4,0)
 ;;=4^Z33.1
 ;;^UTILITY(U,$J,358.3,45787,2)
 ;;=^5062853
 ;;^UTILITY(U,$J,358.3,45788,0)
 ;;=Z13.83^^172^2282^18
 ;;^UTILITY(U,$J,358.3,45788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45788,1,3,0)
 ;;=3^Screening for Repiratory Disorder
 ;;^UTILITY(U,$J,358.3,45788,1,4,0)
 ;;=4^Z13.83
 ;;^UTILITY(U,$J,358.3,45788,2)
 ;;=^5062715
 ;;^UTILITY(U,$J,358.3,45789,0)
 ;;=Z13.820^^172^2282^17
 ;;^UTILITY(U,$J,358.3,45789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45789,1,3,0)
 ;;=3^Screening for Osteoporosis
 ;;^UTILITY(U,$J,358.3,45789,1,4,0)
 ;;=4^Z13.820
 ;;^UTILITY(U,$J,358.3,45789,2)
 ;;=^5062713
 ;;^UTILITY(U,$J,358.3,45790,0)
 ;;=Z23.^^172^2282^4
 ;;^UTILITY(U,$J,358.3,45790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45790,1,3,0)
 ;;=3^Immunization Visit
 ;;^UTILITY(U,$J,358.3,45790,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,45790,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,45791,0)
 ;;=Z01.82^^172^2282^1
 ;;^UTILITY(U,$J,358.3,45791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45791,1,3,0)
 ;;=3^Allergy Testing Visit
 ;;^UTILITY(U,$J,358.3,45791,1,4,0)
 ;;=4^Z01.82
 ;;^UTILITY(U,$J,358.3,45791,2)
 ;;=^5062629
 ;;^UTILITY(U,$J,358.3,45792,0)
 ;;=Z01.84^^172^2282^2
 ;;^UTILITY(U,$J,358.3,45792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45792,1,3,0)
 ;;=3^Antibody Response Exam
 ;;^UTILITY(U,$J,358.3,45792,1,4,0)
 ;;=4^Z01.84
 ;;^UTILITY(U,$J,358.3,45792,2)
 ;;=^5062631
 ;;^UTILITY(U,$J,358.3,45793,0)
 ;;=Z82.5^^172^2282^3
 ;;^UTILITY(U,$J,358.3,45793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45793,1,3,0)
 ;;=3^Family Hx of Asthma
 ;;^UTILITY(U,$J,358.3,45793,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,45793,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,45794,0)
 ;;=Z87.891^^172^2282^14
 ;;^UTILITY(U,$J,358.3,45794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45794,1,3,0)
 ;;=3^Personal Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,45794,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,45794,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,45795,0)
 ;;=E13.9^^173^2283^9
 ;;^UTILITY(U,$J,358.3,45795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45795,1,3,0)
 ;;=3^Diabetes Mellitus w/o Complications,Other Spec
 ;;^UTILITY(U,$J,358.3,45795,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,45795,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,45796,0)
 ;;=R94.8^^173^2283^4
 ;;^UTILITY(U,$J,358.3,45796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45796,1,3,0)
 ;;=3^Abnormal Results of Function Studies of Organs/Systems
 ;;^UTILITY(U,$J,358.3,45796,1,4,0)
 ;;=4^R94.8
 ;;^UTILITY(U,$J,358.3,45796,2)
 ;;=^5019745
 ;;^UTILITY(U,$J,358.3,45797,0)
 ;;=Z63.4^^173^2283^7
 ;;^UTILITY(U,$J,358.3,45797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45797,1,3,0)
 ;;=3^Bereavement
 ;;^UTILITY(U,$J,358.3,45797,1,4,0)
 ;;=4^Z63.4
 ;;^UTILITY(U,$J,358.3,45797,2)
 ;;=^5063168
 ;;^UTILITY(U,$J,358.3,45798,0)
 ;;=Z45.2^^173^2283^5
